• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Putin says Russia is ready for 'serious' peace talks

admin - Latest News - November 28, 2025
admin
6 views 6 secs 0 Comments



Putin says Russia is ready for ‘serious’ peace talks



Source link

TAGS:
PREVIOUS
Louvre Museum to raise prices for non-European visitors
NEXT
Nov. 28, 2025, 11:05 AM ESTBy Jane C. TimmThe suspect in the shooting of two National Guardsmen will be charged with first degree murder, the U.S. Attorney for the District of Columbia Jeanine Pirro said on Friday, following the death of one of the soldiers.”There are certainly many more charges to come, but we are upgrading the initial charges of assault to murder in the first degree,” Pirro said in an interview on Fox News.As of Friday morning, no charges had been filed in federal court or in DC Superior Court against the suspect, according to court records.National Guard soldier Sarah Beckstrom, 20, died on Thanksgiving Day; she was one of two National Guard soldiers who were shot on Wednesday near Farragut Square Metro Station in Washington D.C. The other soldier, 24-year-old Andrew Wolfe, remains hospitalized.”We still have hope. He’s still in critical condition,” Pirro said in the interview. “We are doing everything we can to assist his family and to make sure that they have everything they need during this difficult time for them.”Sarah Beckstrom, left, and Andrew Wolfe, the National Guard members who were shot in Washington D.C., on Wednesday.Nathan Howard / ReutersPirro and FBI Director Kash Patel identified the suspect yesterday as Rahmanullah Lakanwal, who previously worked with the CIA in Afghanistan. He was shot by another National Guardsman. On Friday, she said the execution of search warrants and investigation was ongoing and happening around the clock.”The individual who did this will pay the ultimate price, according to the Attorney General Pam Bondi, as well he should — once and if a jury returns a verdict that we will be seeking in this case,” Pirro said.Jane C. TimmJane C. Timm is a senior reporter for NBC News.Lillie Boudreaux and Gary Grumbach contributed.
Related Post
November 19, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 19, 2025, 1:47 PM ESTBy Sahil KapurWASHINGTON — With a near-unanimous vote in Congress to pass his bill requiring the release of Jeffrey Epstein files, Rep. Ro Khanna, D-Calif., can claim a victory that no other Democratic presidential prospect has achieved: cracking the MAGA coalition.Early polls suggest he’d be a heavy underdog if he runs. But the California Democrat has been traveling to swing states and early contests to test the water for a possible White House bid.Khanna, 49, teamed up with Rep. Thomas Massie, R-Ky., to introduce the Epstein Files Transparency Act in July. The bill requires the Justice Department to release its records related to Epstein, the late financier and convicted sex offender who had connections to a number of powerful figures, within 30 days.Khanna and Massie attracted Republican co-sponsors and just enough signatures to end-run House GOP leaders and force a vote, with MAGA luminaries such as Republican Reps. Marjorie Taylor Greene of Georgia, Nancy Mace of South Carolina and Lauren Boebert of Colorado supporting the measure.It was a rare bipartisan feat, made more difficult by President Donald Trump, who pushed for months to dissuade Republicans from joining the effort. But in the final days, Trump bowed to what increasingly appeared to be an inevitability, flipping his stance and backing it. Party leaders followed him. Every Republican except one joined unanimous Democrats on Tuesday to vote for the measure on the House floor, sending it to the Senate, which passed it unanimously.In an interview in the speaker’s lobby moments before the House vote on his bill, Khanna told NBC News his project contains the building blocks of a national vision.“Whatever role I have, I hope it’s a role in shaping the national future of the Democratic Party and the country,” he said. “We need to build an enduring coalition around a vision of new economic patriotism that can unite the left and right. And the elements of that are to rail against an elite governing class that has created a system that’s not working for ordinary Americans. And then to offer a concrete vision of how we’re going to prioritize the economic independence and success of those forgotten Americans, as opposed to just this billionaire elite class.”He melded the new effort into his larger left-right message, attacking “the Epstein class that has accumulated power and doesn’t play by the rules and has impunity at the expense of ordinary Americans.”Khanna’s approach is unique among Democrats. He doesn’t quite have the fiery rhetoric of other rumored White House hopefuls such as California Gov. Gavin Newsom and Illinois Gov. JB Pritzker, and he doesn’t have the iconic progressive image of New York’s Rep. Alexandria Ocasio-Cortez. Simply put, his willingness to partner with MAGA figures who are detested by liberals may not be a selling point for an angry and fired-up Democratic base.“That’s a criticism I sometimes get,” Khanna quipped.Still, the California Democrat shows his sharp elbows against Republicans at times, most notably positioning himself as a foil to Vice President JD Vance, who’s seen as a potential Republican front-runner in 2028. He’ll often go after him on social media. During a speech in April at Yale Law School, where both Vance and Khanna received their degrees, Khanna drew a comparison between the vice president and Soviet dictator Joseph Stalin. Vance’s office did not return a request for comment.Rep. Ro Khanna says Epstein is a winning issue for Democrats: ‘This is about trust in government’01:23Khanna lacks the national name recognition of other Democrats, including Pete Buttigieg, a former presidential candidate and transportation secretary in the Biden administration, who has also been viewed as a potential 2028 candidate.Not since the 1800s has a House member ascended straight to the presidency; and as an Indian American, Khanna would be looking to make history in more ways than one.But what he has built is a level of trust among Republicans who wouldn’t work with other Democrats. He said he’s done that by “being civil to colleagues” — including some hard-right Republicans — and building trust and partnerships with them, giving them credit, taking his message to “Republican-leaning podcasts” and “treating MAGA voters with respect.”“I have not gotten into Twitter wars with Marjorie Taylor Greene or Lauren Boebert. I have a real friendship with Thomas Massie,” he said. “They trusted me enough not to make it about Donald Trump — from day one, any press conference we did, anything we did, we talked about it being about the survivors, not political.”Khanna said his insistence on seeing the humanity in those GOP lawmakers, who are top Democratic foes, was key to success.“It was the whole thing,” he added. “If I had engaged in those kind of meme wars and others, there’s no way Massie would have worked with me.”The White House downplayed the Khanna-Massie effort, despite the president fighting it for months, saying Trump had already been “calling for transparency,” on the Epstein files “and is now delivering on it with thousands of pages of documents as part of the ongoing Oversight investigation.”Khanna has a different vision of bipartisanship than other Democrats, including former Presidents Joe Biden and Barack Obama, who sought to find the most moderate Republicans and work with them on noncontroversial goals. By contrast, Khanna tends to look for GOP lawmakers to partner with on populist issues that both the left and the right can sell as a rebuke of an entrenched establishment.He has teamed up with Rep. Don Bacon, R-Neb., to repeal Trump’s tariffs on coffee, and with Reps. Brian Fitzpatrick, R-Pa., and Jodey Arrington, R-Texas, to propose congressional term limits. He worked with Republicans to advocate for reining in the government’s warrantless surveillance powers under FISA Section 702 and to prevent U.S. military intervention in Yemen.Massie said Khanna’s approach was instrumental in the success of their Epstein measure. He said he saw an opening when Khanna offered an Epstein amendment in the Rules Committee, and “got every Democrat and one Republican to vote for it.”“Ro gave me the idea, whether he meant to or not,” Massie said. “He’s able to put aside the partisan bomb throwing in order to work across the aisle, and he’s really good on TV.”“He was an important element of this,” the Kentucky Republican said. “And it was his idea, really, to organize the survivor press conference. So I don’t know if it would have succeeded with any other Democrat on the other side of the aisle.”Others have nothing to say about Khanna, including Rep. Keith Self, R-Texas, who replied, “No comment,” when asked about his role in the Epstein bill.On the House floor before the vote, Khanna thanked his Republican partners on the bill. “The Epstein class is going to go,” he said. “And the reason they’re gonna go is the progressive left and the MAGA right and everyone in between is finally waking up against this rotten system.”In the NBC News interview, Khanna repeatedly invoked President Franklin Delano Roosevelt as a guidepost for his populist views and desire to take on wealthy interests, while conceding that his progressive ideals won’t fully upend the MAGA coalition. But he believes he has a better theory of how to engage those voters than some recent — unnamed — Democratic presidential prospects.“Do I think somehow we’re going to win all of Trump’s voters? No. I’m not naive,” he said. “But I think that that has a better shot of winning than we’re just going to do Infrastructure 2.0.”Sahil KapurSahil Kapur is a senior national political reporter for NBC News.
September 26, 2025
Sinclair to resume airing 'Jimmy Kimmel Live!'
November 30, 2025
Nov. 30, 2025, 6:00 AM ESTBy David CoxIn early 2023, Liana Shatova began taking low doses of an antidepressant to ease symptoms of a premenstrual disorder marked by mood swings, anxiety and depression. At first, the difference was remarkable for her. “I felt full of energy and could juggle multiple things at once,” said Shatova, 40, a business development manager from the Greater Boston area. Then, after around 18 months on the medication, she started to fear she was becoming emotionally numb.“My best friend’s mom died unexpectedly, everyone was in shock and sobbing, and I couldn’t cry at all,” said Shatova. “I just felt nothing.” When Shatova asked her doctor if she could stop taking the medication sertraline, an antidepressant better known by its brand name Zoloft, she said she was reassured that she was on the lowest prescribed dose and that coming off it wouldn’t be difficult.Initially all seemed well, but after a month, Shatova said she experienced her first bout of what would become chronic insomnia, followed by panic attacks. Other symptoms emerged, including night sweats, muscle and joint pain and mood swings that left her unable to work. She said her doctor told her that the symptoms were a relapse of her premenstrual dysphoric disorder, and suggested a different antidepressant. Shatova declined the new drug.Antidepressants, primarily SSRIs, or selective serotonin reuptake inhibitors, are some of the most widely prescribed medications in the United States, taken by tens of millions of adults. About twice as many women as men report using an antidepressant in the past 30 days, with antidepressant use highest among women aged 60 and older, according to government data.Side effects are a key reason people choose to go off their medication, but stopping the drugs can also lead to withdrawal symptoms, research indicates. Along with the growing awareness, a deprescribing movement is building up in the field of psychiatry, aimed at helping patients reduce or stop their medications when no longer considered necessary. In a recent large analysis published in The Lancet in November, researchers at King’s College London found that physical side effects, including quick weight gain, significantly increased heart rate or elevated blood pressure, may be more common than once thought, depending on the drug. The review analyzed results from 151 clinical trials and 17 reports from the Food and Drug Administration, involving about 30 different prescription drugs used to treat depression, anxiety, and bipolar and panic disorders. The researchers examined the effects of antidepressants on weight, blood glucose, total cholesterol, blood pressure and heart rate. They didn’t look at emotional changes experienced by patients such as Shatova, although the lead study author said it should be examined further in future studies. “Not all antidepressants are built the same when it comes to their physical health side effects,” said Dr. Toby Pillinger, an academic clinical lecturer at King’s College London, who led the study. “Up until recently, we’ve approached antidepressant prescribing with a one-size-fits-all policy, and I think we need to move away from that.”Separately, in August, psychiatry researchers in the U.K. found that serious withdrawal effects may be more common than previously suspected, especially with longer-term use, although the study was small with just 18% of participants responding to the survey. The results showed that among people who had been taking antidepressants for more than two years, 63% reported moderate or severe withdrawal effects, with a third describing withdrawal issues that lasted more than three months. Symptoms ranged from insomnia to confusion, electric sensations, muscle cramps, agitation, mood swings and derealisation or an alteration in the person’s perception of the world. Dr. Mark Horowitz, a clinical research fellow at University College London who led the withdrawal study, said other research has found that roughly a quarter of patients experience severe symptoms when they abruptly stop taking their medications, from burning pain in the skin or limbs, balance problems, ongoing panic attacks, and sound and light sensitivity. Abrupt cessation of antidepressants is not recommended, but research has found that withdrawal symptoms can occur even when people attempt to taper. A review of various existing studies published last year by a group of German psychiatrists concluded that as many as 1 in 3 antidepressant users will experience some kind of withdrawal symptoms, with severe symptoms occurring in 1 in 30 users. Dr. Joseph Goldberg, clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York, said that antidepressants have long been known to cause “discontinuation symptoms,” mainly nausea and dizziness, particularly if stopped abruptly.It’s unclear why some patients have severe symptoms after stopping their medications. Some researchers, concerned by reports of antidepressant withdrawal, suggest that the underlying mechanisms are similar to those faced by people suffering from alcohol and opiate withdrawal. “Withdrawal symptoms tell you that your brain is trying to restore a balance that it was forced to change by the presence of a drug,” said David Cohen, professor of social welfare at the University of California Los Angeles. “I think it’s the best accepted explanation for why stopping any centrally active drug, whether its antidepressants, coffee or heroin, leads to some discomfort.”The challenge for psychiatrists is that the drugs, which are often prescribed along with therapy, do help many people, particularly in the short term. Dr. Jonathan Alpert, a psychiatry professor at Albert Einstein College of Medicine, said that anecdotes of extreme withdrawal do not reflect his own professional experience. In his practice, Alpert estimated that two-thirds of his patients have been on antidepressants for more than five years, and only a small handful had experienced protracted withdrawal symptoms lasting more than a few days.“There’s been this very inflated idea that it’s really difficult to come off psychiatric medications,” said Alpert. “Even though I respect people’s narratives of their own experience, it feels very different from what we see in clinical practice and research studies.”Goldberg also expressed skepticism as to whether antidepressants themselves are actually responsible for the symptoms being reported by patients. “If somebody, after years of treatment, develops some frankly rather peculiar and unexpected neurological problems, I’m not sure how confident one can attribute that to medicine,” he said. “Anything is possible. But I think we have to consider the more likely possibility that the thing they’re encountering may be unrelated.” More than a year after Shatova first attempted to taper off the medication, she said she’s still undergoing a painstaking process of tiny, gradual reductions to try to avoid exacerbating her symptoms. “I am still tapering and now at 0.835 mg of Zoloft, doing it very slowly and carefully,” she said. “My sleep has gotten better, but I still have windows and waves triggered by life stresses and hormonal fluctuations.” It’s important not to dismiss people’s experiences, Goldberg said, and anyone going through symptoms should undergo further testing. A past president of American Society of Clinical Psychopharmacology, Goldberg said that the organization is now completing new guidelines on deprescribing. The goal is to help doctors explain what to expect when stopping psychiatric medications so patients don’t self-taper without medical supervision.Alpert suggested analyzing different types of data stored in electronic health records to get insight into the characteristics of patients who have prolonged withdrawal symptoms. “Do they have abnormal MRIs or blood tests with inflammatory markers? Through looking at large datasets, it will be more possible to identify predictors of this subset of people who seem to have unusually prolonged symptoms.”Cohen feels that the field of psychiatry needs to speed up research. However, in the wake of the 43% cut to the National Institutes of Health annual budget proposed to Congress by the current administration, a figure which is equivalent to $20 billion per year, it is likely that such studies would need to be carried out by either U.K. or European researchers. “We need large, nonindustry funded trials to examine what happens when people stop antidepressants, using various tapering strategies and long enough follow-up,” Cohen said. “We need dozens of such trials now.”If you or someone you know is in crisis, call or text 988, or go to 988lifeline.org, to reach the Suicide & Crisis Lifeline. You can also call the network, previously known as the National Suicide Prevention Lifeline, at 800-273-8255, or visit SpeakingOfSuicide.com/resources.David CoxDavid Cox is a freelance journalist focusing on all aspects of health, from fitness and nutrition to infectious diseases and future medicines. Prior to becoming a full-time journalist, he was a neuroscientist attempting to understand how and why the brain goes wrong.
October 22, 2025
Eyewitness reacts to ICE raids in New York's Chinatown
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved